Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 1/20 | 0.71 |
| ▸ | HTT | P42858 | 3/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.68 |
| ▸ | EGFR | P00533 | 3/20 | 0.64 |
| ▸ | BRAF | P15056 | 3/20 | 0.64 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.63 |
| ▸ | HCK | P08631 | 3/20 | 0.62 |
| ▸ | NR2C2 | P49116 | 1/20 | 0.62 |
| ▸ | CLK1 | P49759 | 1/20 | 0.60 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.60 |
| ▸ | BTK | Q06187 | 2/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.60 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.60 |
| ▸ | MAP3K20 | Q9NYL2 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2280193 | 0.97 | RAD52 (0.75) | RAD52HTTMAPK1ATMEGFR | |
| SCHEMBL19986849 | 0.87 | RAD52 (0.81) | RAD52HTTMAPK1ATMDDR1 | |
| SCHEMBL2226738 | 0.87 | RAD52 (0.82) | RAD52HTTMAPK1ATMEGFR | |
| SCHEMBL17208696 | 0.85 | RAD52 (0.80) | RAD52HTTMAPK1ATMDDR1 | |
| SCHEMBL17208720 | 0.85 | RAD52 (0.95) | RAD52HTTMAPK1ATMDDR1 | |
| SCHEMBL17208642 | 0.85 | RAD52 (0.79) | RAD52HTTMAPK1ATMDDR1 | |
| SCHEMBL22457642 | 0.84 | RAD52 (0.78) | RAD52HTTMAPK1ATMDDR1 | |
| SCHEMBL2228555 | 0.84 | RAD52 (0.84) | RAD52HTTMAPK1ATMDDR1 | |
| SCHEMBL31620784 | 0.84 | BRAF (0.73) | EGFRBRAF | |
| SCHEMBL2280189 | 0.82 | HCK (0.60) | HTTMAPK1ATMEGFRBRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2937345-B1 | TYPE II RAF KINASE INHIBITORS | DANA FARBER CANCER INST INC (US) | 2018-03-21 | — | — | EP | disclosed |
| EP-2937345-A2 | Type II raf kinase inhibitors | Dana-Farber Cancer Institute, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |